Hikma Pharmaceuticals (PK)【HKMPF】銘柄情報

Hikma Pharmaceuticals Plc (PK) (HKMPF) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

20.115

( - )

買値

20.115

売値

20.115

出来高

0.00 日の範囲 0.00

16.3425 52 週間の範囲 27.96

時価総額

4.285B

前日終値

20.115

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

US$ 862,260

発行済株式数

213,030,512

配当利回り

0.84

PER

11.18

1 株当たり利益 (EPS)

1.81

歳入

3.35B

純利益

402M

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primari... Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The Hikma Rx segment offers oral, respiratory, and other generic and specialty products for the retail market. It provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company also offers its products in solid, semi-solid, liquid, and injectable dosage forms. It operates in the United Kingdom, Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, United Kingdom. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

www.hikma.com

本社

London, United Kingdom

設立

1978

Hikma Pharmaceuticals Plc (PK) is listed in the Healthcare sector of the その他OTC with ticker HKMPF. The last closing price for Hikma Pharmaceuticals (PK) was US$20.12. Over the last year, Hikma Pharmaceuticals (PK) shares have traded in a share price range of US$ 16.3425 to US$ 27.96.

Hikma Pharmaceuticals (PK) currently has 213,030,512 shares in issue. The market capitalisation of Hikma Pharmaceuticals (PK) is US$4.29 billion. Hikma Pharmaceuticals (PK) has a price to earnings ratio (PE ratio) of 11.18.

BNY Mellon Appointed as Depositary Bank by Hikma Pharmaceuticals PLC

NEW YORK, Sept. 29 /PRNewswire-FirstCall/ -- BNY Mellon, the global leader in asset management and securities servicing, has been selected by...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	20.115	20.115	20.115	1125	20.115	CS
4	0	0	20.115	20.115	20.115	1125	20.115	CS
12	2.115	11.75	18	20.115	18	859	18.4632945	CS
26	-0.675	-3.24675324675	20.79	22.555	16.3425	773	19.14294288	CS
52	-6.685	-24.9440298507	26.8	27.96	16.3425	1191	21.60992013	CS
156	-3.005	-12.9974048443	23.12	28.915	16.3425	1226	23.39320219	CS
260	-14.385	-41.6956521739	34.5	38.5	13.76	1219	23.99368598	CS